IRIS
MARTORANA, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 30.993
AS - Asia 4.373
EU - Europa 3.540
SA - Sud America 555
Continente sconosciuto - Info sul continente non disponibili 477
AF - Africa 74
OC - Oceania 13
Totale 40.025
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 30.829
SG - Singapore 2.224
IT - Italia 912
CN - Cina 701
BR - Brasile 459
DE - Germania 456
RU - Federazione Russa 434
UA - Ucraina 394
HK - Hong Kong 369
VN - Vietnam 316
IE - Irlanda 299
FR - Francia 238
BD - Bangladesh 233
GB - Regno Unito 200
KR - Corea 133
FI - Finlandia 128
NL - Olanda 123
JP - Giappone 115
SE - Svezia 112
PL - Polonia 95
CA - Canada 90
IN - India 67
AR - Argentina 40
AT - Austria 31
TR - Turchia 28
ID - Indonesia 27
MX - Messico 27
ES - Italia 26
ZA - Sudafrica 23
CZ - Repubblica Ceca 20
UZ - Uzbekistan 20
BE - Belgio 18
EC - Ecuador 17
IQ - Iraq 17
KG - Kirghizistan 14
PH - Filippine 14
SA - Arabia Saudita 14
CL - Cile 13
AU - Australia 12
EU - Europa 12
PK - Pakistan 12
CR - Costa Rica 11
KE - Kenya 11
MY - Malesia 10
MA - Marocco 9
PY - Paraguay 9
JM - Giamaica 8
JO - Giordania 8
TN - Tunisia 8
DK - Danimarca 6
VE - Venezuela 6
BG - Bulgaria 5
CH - Svizzera 5
CO - Colombia 5
IL - Israele 5
IR - Iran 5
LT - Lituania 5
NP - Nepal 5
RO - Romania 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
EG - Egitto 4
ET - Etiopia 4
GR - Grecia 4
HN - Honduras 4
NO - Norvegia 4
OM - Oman 4
PE - Perù 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
CG - Congo 3
MD - Moldavia 3
PS - Palestinian Territory 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
DM - Dominica 2
DZ - Algeria 2
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
KY - Cayman, isole 2
KZ - Kazakistan 2
LB - Libano 2
NG - Nigeria 2
PA - Panama 2
RS - Serbia 2
SC - Seychelles 2
SI - Slovenia 2
SV - El Salvador 2
UY - Uruguay 2
ZM - Zambia 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BM - Bermuda 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BY - Bielorussia 1
Totale 39.540
Salva come PNG Salva come JPEG
Città #
Woodbridge 8.025
Wilmington 7.326
Houston 7.097
Fairfield 1.069
Singapore 1.004
Ashburn 697
Ann Arbor 667
San Jose 590
Chandler 466
Seattle 437
Hong Kong 363
Cambridge 344
Jacksonville 331
Beijing 286
Dublin 279
Rome 255
Council Bluffs 250
Medford 218
Dearborn 211
New York 200
Santa Clara 159
Los Angeles 126
The Dalles 110
Ho Chi Minh City 103
Lawrence 102
Tokyo 101
Moscow 80
Lauterbourg 73
Hanoi 72
Munich 72
Buffalo 70
Milan 65
Kraków 62
San Diego 60
Mülheim 51
São Paulo 46
Helsinki 44
Menlo Park 43
Chicago 42
Zhengzhou 42
Dallas 39
Manchester 35
London 32
Atlanta 31
Brooklyn 29
Norwalk 29
Palo Alto 28
Warsaw 28
Naples 27
Redondo Beach 24
Toronto 24
Maastricht 23
Nuremberg 23
Orem 23
Rio de Janeiro 21
Redwood City 20
Chennai 19
Johannesburg 19
Monte Vista 19
Montreal 19
North Bergen 19
Phoenix 19
Brussels 18
Hangzhou 18
Vienna 18
Amsterdam 17
Boardman 17
Da Nang 17
San Francisco 17
Verona 17
Düsseldorf 16
Frankfurt am Main 16
Brno 15
Columbus 15
Shanghai 15
Tashkent 15
Stockholm 14
Bologna 13
Memphis 13
Poplar 13
Seoul 13
Denver 12
Dhaka 12
Falls Church 12
Hefei 12
Jakarta 12
Miami 12
University Park 12
Belo Horizonte 11
Florence 11
Guangzhou 11
Madrid 11
Mexico City 11
Palermo 11
Pieve a Nievole 11
Saint Petersburg 11
Turku 11
Biên Hòa 10
Brasília 10
Brescia 10
Totale 32.698
Salva come PNG Salva come JPEG
Nome #
Opioid-mediated modulation of calcium currents in striatal and pallidal neurons following reserpine treatment: focus on kappa response. 598
Transcranial magnetic stimulation of the precuneus enhances memory and neural activity in prodromal Alzheimer's disease 526
Down-regulation of nitrergic transmission in the rat striatum after chronic nigrostriatal deafferentation 520
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis. 508
Association between alzheimer's disease and glaucoma: A study based on heidelberg retinal tomography and frequency doubling technology perimetry 506
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis 501
Transient global amnesia: linked to a systemic disorder of amino acid catabolism? 500
Manganese intoxication decreases the expression of manganoproteins in the rat basal ganglia: an immunohistochemical study. 493
Assessment of Optic Nerve Head and Retinal Nerve Fibre Layer Changes and Evaluation of Frequency of Glaucoma in Patients with Alzheimer's Disease 485
Altered dopamine modulation of LTD-like plasticity in Alzheimer’s disease patients 484
Beneficial effects of rolipram in a quinolinic acid model of striatal excitotoxicity. 483
Beyond the cholinergic hypothesis: do current drugs work in Alzheimer's disease? 483
Impaired LTP- but not LTD-Like Cortical Plasticity in Alzheimer's Disease Patients 475
Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis 474
"Homotaurine induces measurable changes of short latency afferent inhibition in a group of mild cognitive impairment individuals" 473
Sub-cellular localization of manganese in the basal ganglia of normal and manganese-treated rats An electron spectroscopy imaging and electron energy-loss spectroscopy study. 470
Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease 469
Cerebrospinal fluid levels of Aβ42 relationship with cholinergic cortical activity in Alzheimer's disease patients 468
Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease 468
PDE10A and PDE10A-dependent cAMP catabolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: a key step in parkinsonism physiopathology 467
Differential post-translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid. 466
Adult polyglucosan body disease: Proton magnetic resonance spectroscopy of the brain and novel mutation in the GBE1 gene 465
A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus 461
Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington's disease 459
Bromelain degrades Aβ1-42 monomers and soluble aggregates: an in vitro study in cerebrospinal fluid of Alzheimer's disease patients 459
Oligodendrocytes express P2Y12 metabotropic receptor in adult rat brain 458
Levodopa-induced dyskinesias are associated with transient down-regulation of cAMP and cGMP in the caudate-putamen of hemiparkinsonian rats: Reduced synthesis or increased catabolism? 454
Dopamine D2-agonist Rotigotine effects on cortical excitability and central cholinergic transmission in Alzheimer's disease patients 454
Dopamine denervation induces neurotensin immunoreactivity in GABA-parvalbumin striatal neurons 451
Dopaminergic Modulation of Cortical Plasticity in Alzheimer's Disease Patients 447
Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis 445
Neurotensin effects on N-type calcium currents among rat pallidal neurons: an electrophysiological and immunohistochemical study. 445
Amyloid β, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track? 443
P2Y1 receptor switches to neurons from glia in juvenile versus neonatal rat cerebellar cortex 441
CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD 441
Huntingtin distribution among striatal output neurons of normal rat brain 440
Differential post-translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid. 440
Immunolocalization of CB1 receptor in rat striatal neurons: a confocal microscopy study 439
Glaucoma progression associated with altered cerebral spinal fluid levels of amyloid beta and tau proteins 437
Distribution of TRPC1 receptors in dendrites of rat substantia nigra: a confocal and electron microscopy study. 437
Oligodendrocytes express P2Y12 metabotropic receptor in adult rat brain. 434
Cerebrospinal-fluid orexin levels and daytime somnolence in frontotemporal dementia 433
Reversal of LTP-Like cortical plasticity in Alzheimer's disease patients with tau-related faster clinical progression 433
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 429
Cellular localization of TRPC3 channel in rat brain: preferential distribution to oligodendrocytes. 426
Tissue plasminogen activator is required for corticostriatal long-term potentiation 424
In vivo electrophysiology of dopamine-denervated striatum: focus on the nitric oxide/cGMP signaling pathway. 424
Abeta1-42 Detection in CSF of Alzheimer's disease is influenced by handling temperature: indication of reversible Abeta1-42 aggregation? 422
Enkephalin, neurotensin, and substance P immunoreactivite neurones of the rat GP following 6-hydroxydopamine lesion of the substantia nigra 420
Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington's disease. 419
Effects of simvastatin on neuroprotection and modulation of Bcl-2 and BAX in the rat quinolinic acid model of Huntington's disease. 418
Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis 417
Detection of Aβ42 in the CSF of Alzheimer’s disease is influenced by handling temperature: indication of a reversible process of Aβ42 aggregation in vivo? 416
Cellular localization of TRPC3 channel in rat brain: preferential distribution to oligodendrocytes. 415
D2-mediated modulation of N-type calcium currents in rat globus pallidus neurons following dopamine denervation 414
CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment 413
Kyphoplasty: a new opportunity for rehabilitation of neurologic disabilities 410
Activation of beta1-adrenoceptors excites striatal cholinergic interneurons through a cAMP-dependent, protein kinase-independent pathway 409
L-dopa modulates motor cortex excitability in Alzheimer's disease patients 409
Plasmin system of Alzheimer's disease patients: CSF analysis 408
Functional correlates of t-Tau, p-Tau and Aβ1-42 amyloid cerebrospinal fluid levels in Alzheimer's disease: A 18F-FDG PET/CT study 400
Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms 395
Intracellular localization and isoform expression of the voltage-dependent anion channel (VDAC) in normal and dystrophic skeletal muscle 392
Frailty among Alzheimer's disease patients 388
Is dopamine involved in Alzheimer's disease? 388
Zinc distribution in various tissues, (brain, eye, skin, muscle and blood) of rat during hindlimb suspension 380
Dopamine modulates cholinergic cortical excitability in Alzheimer's disease patients 377
Distribution of TRPC1 receptors in dendrites of rat substantia nigra: a confocal and electron microscopy study. 371
CSF tau is associated with impaired cortical plasticity, cognitive decline and astrocyte survival only in APOE4-positive Alzheimer's disease 371
Dopamine Modulates Cholinergic Cortical Excitability in Alzheimer's Disease Patients. 366
The Load of Amyloid-β Oligomers is Decreased in the Cerebrospinal Fluid of Alzheimer's Disease Patients 362
Muscle regeneration in mdx mice: Resistance to repeated necrosis is compatible with myofiber maturity 361
Long-term potentiation-like cortical plasticity is disrupted in Alzheimer's disease patients independently from age of onset 355
Functional correlates of TSH, fT3 and fT4 in Alzheimer disease: A F-18 FDG PET/CT study 322
Is cerebral glucose metabolism related to blood-brain barrier dysfunction and intrathecal IgG synthesis in Alzheimer disease? A 18F-FDG PET/CT study 318
Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study 310
Assessment of serum uric acid as risk factor for tauopathies 309
Effects of palmitoylethanolamide combined with luteoline on frontal lobe functions, high frequency oscillations, and GABAergic transmission in patients with frontotemporal dementia 273
Precuneus magnetic stimulation for Alzheimer's disease: a randomized, sham-controlled trial 268
Comparison between Early-Onset and Late-Onset Alzheimer's Disease Patients with Amnestic Presentation: CSF and 18F-FDG PET Study 236
The role of epsilon phenotype in brain glucose consumption in Alzheimer’s disease 228
Alzheimer’s disease and the routine clinical use of CSF biomarkers 207
LTP-like cortical plasticity is associated with verbal memory impairment in Alzheimer's disease patients. 205
Effect of Rotigotine vs Placebo on Cognitive Functions Among Patients With Mild to Moderate Alzheimer Disease: A Randomized Clinical Trial 194
Amyloid-Mediated Cholinergic Dysfunction in Motor Impairment Related to Alzheimer's Disease 189
Levels of amyloid-beta-42 and CSF pressure are directly related in patients with Alzheimer's disease. 183
LTP-like cortical plasticity predicts conversion to dementia in patients with memory impairment 182
Protective role of cerebrospinal fluid inflammatory cytokines in patients with amnestic mild cognitive impairment and early Alzheimer's disease carrying apolipoprotein E4 genotype 175
Classification Accuracy of Transcranial Magnetic Stimulation for the Diagnosis of Neurodegenerative Dementias 160
Effects of cerebellar theta burst stimulation on contralateral motor cortex excitability in patients with Alzheimer’s disease 160
Insulin and the future treatment of Alzheimer’s disease 159
Ageing as a Trait de Union between diabetes and dementia for frailty 153
Cerebrospinal Fluid Aβ42 Levels: When Physiological Become Pathological State 147
Transcranial magnetic stimulation: emerging biomarkers and novel therapeutics in Alzheimer's disease 138
Cognitive reserve and Alzheimer's biological continuum: clues for prediction and prevention of dementia 124
Autonomic Dysfunction in Patients With Dementia With Lewy Bodies and Its Relationship With Nigrostriatal Denervation 123
Brain energy metabolism and neurodegeneration: hints from CSF lactate levels in dementias 117
Diabetes Mellitus contributes to higher cerebrospinal fluid tau levels selectively in Alzheimer's disease patients with APOE4 genotype 113
Breakdown of TMS evoked EEG signal propagation within the default mode network in Alzheimer’s disease 113
The brain metabolic correlates of the main indices of neuropsychological assessment in Alzheimer’s disease 109
Totale 37.347
Salva come PNG Salva come JPEG
Categoria #
all - tutte 99.706
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.706
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.112 0 158 86 37 32 114 55 88 71 80 73 318
2022/20231.285 144 111 45 131 100 297 109 58 114 16 109 51
2023/2024498 58 16 31 25 42 148 20 44 10 10 6 88
2024/20253.079 84 631 289 162 77 222 132 117 305 259 405 396
2025/20265.675 394 230 523 439 480 180 745 662 681 525 470 346
2026/2027816 476 340 0 0 0 0 0 0 0 0 0 0
Totale 40.025